Sws Partners Guardant Health, Inc. Transaction History
Sws Partners
- $352 Million
- Q2 2025
A detailed history of Sws Partners transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sws Partners holds 93,077 shares of GH stock, worth $4.4 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
93,077
Previous 104,817
11.2%
Holding current value
$4.4 Million
Previous $4.47 Million
8.47%
% of portfolio
1.38%
Previous 1.54%
Shares
16 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$571 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$531 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$257 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$243 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$239 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.83B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...